Esperante

Esperante email format

Verified email-pattern data for Esperante is currently limited. You can still use the company insights and contact sections below.
Esperante is a corporate venture capital company as an affiliate of a privately-owned global life science group. The leadership is experienced in the operational management of life science companies and specifically on the development, manufacturing and marketing of prescription pharmaceuticals and in vitro clinical diagnostic tests on a worldwide basis. Esperante was established in 2004 and has to date completed 24 pharmaceutical and diagnostic company investments across the US, UK, continental Europe and Israel. 3 exits have been delivered to date: Thiakis (UK) to Wyeth/Pfizer (US), Pinnacle Biologics (US) to Concordia (Canada) and Haemostatix (UK) to Ergomed (UK). 4 portfolio companies are currently publicly listed in the US, Canada and UK. The therapeutics portfolio companies are mainly in Phase 2 or 3 clinical development and two diagnostics companies are in European commercial launch phase. Esperante currently seeks to make initial investments of up to EUR 2,000,000 each in syndication with other investors with the intent of generating exit through sale or other liquidity outcomes within a period of 3 years.

Company Details

Employees
2
Founded
-
Address
Siriusdreef, Hoofddorp,north Holland 2132,netherlands
Industry
Venture Capital And Private Equity Principals
Keywords
Paris.
HQ
Hoofddorp, North Holland
Looking for a particular Esperante employee's phone or email?

Esperante Questions

Explore related pages

Related company profiles:

Top Esperante Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant